Benzinga | Nov 3, 2021 04:35PM EDT

CRISPR Therapeutics Q3 Sales $300.00K Up From $148.00K YoY

CRISPR Therapeutics (NASDAQ:CRSP) reported $300.00 thousand in sales this quarter. This is a 102.70 percent increase over sales of $148.00 thousand the same period last year.